|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 04743483.2 (espacenet) (Federated) (European Patent Register), 20040720 | | Patent/reg. no. and date | DK/EP 1646639, 20160817 | | Publication date | 20060419 | | Priority no. and date | GB 0317009, 20030721 | | EP pub. no. and date |
EP 1646639 20060419 | | Effective date | | | Applicant/owner | NuCana plc, 77-78 Cannon Street
London EC4N 6AF, GB | | Applicant ref. no. | V1608-017-DK | | Inventor | McGUIGAN, Christopher, 2 Alfreda Road
Whitchurch,
Cardiff CF4 2EH, GB | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/7068 (2006.01) , A61K 31/7072 (2006.01) , A61P 35/00 (2006.01) , C07H 19/10 (2006.01) | | Title | NUKLEOTIDPHOSPHORAMIDATER SOM ANTICANCERMIDLER | | Int. application no. | GB2004003148 | | Int. publication no. | WO2005012327 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
